People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...

Going from a hot and sweaty commute to the cold office—not to mention, the erratic rain—can spell trouble for the everyday ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

Researchers at Radboud University and the Radboudumc found that mothers with postpartum depression benefit from oxytocin ...

A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

Can nasal polyps be removed without surgery? Learn about treatment options and success rates, including nasal sprays, oral medications, nasal polyp suction, and antibiotics.

A new study shows that oxytocin nasal spray helps mothers with postpartum depression interact more positively with their babies.

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in the ...